Axa
ATRA icon

Axa’s Atara Biotherapeutics ATRA Stock Holding History

Axa’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-425
Closed -$165K – 1229
2021
Q2 		$165K Sell
425
-1,544
-78% -$551K ﹤0.01% 1228
2021
Q1 		$707K Sell
1,969
-5,913
-75% -$2.61M ﹤0.01% 1034
2020
Q4 		$3.87M Sell
7,882
-128
-2% -$59.1K 0.01% 742
2020
Q3 		$2.6M Hold
8,010
– – 0.01% 770
2020
Q2 		$2.92M Buy
8,010
+4,208
+111% +$1.06M 0.01% 749
2020
Q1 		$809K Sell
3,802
-1,714
-31% -$544K ﹤0.01% 888
2019
Q4 		$2.27M Buy
5,516
+4,727
+599% +$1.63M 0.01% 786
2019
Q3 		$279K Buy
+789
New +$294K ﹤0.01% 1195

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return